Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Ena Respiratory Pty Ltd. has 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are being handled by 2 distinct examiners. Both actions are located within 1 distinct art unit, indicating a focused technical area for the company's current active applications. This allows for a comparison of how different examiners handle similar subject matter within the same technical group.
Aldarondo, Dasia Ali is the busiest examiner for the portfolio, overseeing 1 pending office action. Since there are 2 pending actions and two distinct examiners, each examiner is responsible for one action. This setup allows the company to interact with two different examiners within the same art unit, providing a concentrated but varied view of the prosecution process. Practitioners should monitor the distinct approaches of these examiners to identify any variations in prosecution style.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALDARONDO, DASIA ALI | 1 | 0.0% | +0.0% |
| COUGHLIN, MATTHEW P | 1 | 71.3% | +12.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18687841 | ALLERGY TREATMENT | ALDARONDO, DASIA ALI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17926886 | TREATMENT OF CORONAVIRUS | COUGHLIN, MATTHEW P | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18687841 | ALLERGY TREATMENT | ALDARONDO, DASIA ALI | — | §102§103§112DP | Non-Final OA | — | Pending | Feb 29, 2024 |
| 17926886 | TREATMENT OF CORONAVIRUS | COUGHLIN, MATTHEW P | 1626 | §103§112DP | Final Rejection | — | Pending | Nov 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial